Pacific Biosciences Of California (PACB) Raw Materials (2011 - 2026)

Pacific Biosciences Of California has reported Raw Materials for 16 years, with the latest figure at $28.0 million in Q2 2026.

• On a quarterly basis, Raw Materials fell 39.08% year-over-year to $28.0 million in Q2 2026; TTM through Jun 2026 was $28.0 million, a 39.08% decrease from a year earlier, with the FY2025 full-year figure at $22.5 million, down 50.23% from the prior year.
• Raw Materials was $28.0 million for Q2 2026 at Pacific Biosciences Of California, down from $34.7 million in the prior quarter.
• The five-year high for Raw Materials was $46.0 million in Q2 2025, with the low at $11.5 million in Q1 2022.
• Average Raw Materials over 5 years is $29.2 million, with a median of $26.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Raw Materials soared 202.0% in 2022, then sank 50.23% in 2025.
• Over 5 years, Raw Materials stood at $24.1 million in 2022, then soared by 34.36% to $32.4 million in 2023, then jumped by 39.58% to $45.3 million in 2024, then tumbled by 50.23% to $22.5 million in 2025, then climbed by 24.27% to $28.0 million in 2026.
• The last three Raw Materials figures came in at $28.0 million (Q2 2026), $34.7 million (Q1 2026), and $22.5 million (Q4 2025), per Business Quant data.